Online citations, reference lists, and bibliographies.
← Back to Search

Novel Reproductive Technologies To Prevent Mitochondrial Disease

L. Craven, M. Tang, G. Gorman, P. De Sutter, B. Heindryckx
Published 2017 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND The use of nuclear transfer (NT) has been proposed as a novel reproductive treatment to overcome the transmission of maternally-inherited mitochondrial DNA (mtDNA) mutations. Pathogenic mutations in mtDNA can cause a wide-spectrum of life-limiting disorders, collectively known as mtDNA disease, for which there are currently few effective treatments and no known cures. The many unique features of mtDNA make genetic counselling challenging for women harbouring pathogenic mtDNA mutations but reproductive options that involve medical intervention are available that will minimize the risk of mtDNA disease in their offspring. This includes PGD, which is currently offered as a clinical treatment but will not be suitable for all. The potential for NT to reduce transmission of mtDNA mutations has been demonstrated in both animal and human models, and has recently been clinically applied not only to prevent mtDNA disease but also for some infertility cases. In this review, we will interrogate the different NT techniques, including a discussion on the available safety and efficacy data of these technologies for mtDNA disease prevention. In addition, we appraise the evidence for the translational use of NT technologies in infertility. OBJECTIVE AND RATIONALE We propose to review the current scientific evidence regarding the clinical use of NT to prevent mitochondrial disease. SEARCH METHODS The scientific literature was investigated by searching PubMed database until Jan 2017. Relevant documents from Human Fertilisation and Embryology Authority as well as reports from both the scientific and popular media were also implemented. The above searches were based on the following key words: 'mitochondria', 'mitochondrial DNA'; 'mitochondrial DNA disease', 'fertility'; 'preimplantation genetic diagnosis', 'nuclear transfer', 'mitochondrial replacement' and 'mitochondrial donation'. OUTCOMES While NT techniques have been shown to effectively reduce the transmission of heteroplasmic mtDNA variants in animal models, and increasing evidence supports their use to prevent the transmission of human mtDNA disease, the need for robust, long-term evaluation is still warranted. Moreover, prenatal screening would still be strongly advocated in combination with the use of these IVF-based technologies. Scientific evidence to support the use of NT and other novel reproductive techniques for infertility is currently lacking. WIDER IMPLICATIONS It is mandatory that any new ART treatments are first adequately assessed in both animal and human models before the cautious implementation of these new therapeutic approaches is clinically undertaken. There is growing evidence to suggest that the translation of these innovative technologies into clinical practice should be cautiously adopted only in highly selected patients. Indeed, given the limited safety and efficacy data, close monitoring of any offspring remains paramount.
This paper references
10.1093/HUMUPD/7.4.428
Cytoplasmic transfer in assisted reproduction.
J. Barritt (2001)
10.1016/j.cmet.2016.06.012
Incompatibility between Nuclear and Mitochondrial Genomes Contributes to an Interspecies Reproductive Barrier.
H. Ma (2016)
Healthy baby girl born following preimplantation genetic diagnosis for mitochondrial DNA M.8993t > G mutation
DR Thorburn (2009)
10.1016/j.jmig.2009.01.008
Cumulative Live-birth Rates after In Vitro Fertilization
S. Corson (2009)
10.1042/BST20160095
Modulating mitochondrial quality in disease transmission: towards enabling mitochondrial DNA disease carriers to have healthy children
A. Diot (2016)
10.1007/s10815-013-0062-6
Embryo developmental capability and pregnancy outcome are related to the mitochondrial DNA copy number and ooplasmic volume
Yukitaka Murakoshi (2013)
10.1073/PNAS.0506197102
Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantation.
A. Sato (2005)
10.1093/MOLEHR/GAH243
Mitochondrial DNA content and 4977 bp deletion in unfertilized oocytes.
C. W. Chan (2005)
10.1017/S0963180100006071
Germ-line therapy to cure mitochondrial disease: protocol and ethics of in vitro ovum nuclear transplantation.
D. Rubenstein (1995)
10.1093/nar/gkv1003
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins
S. Calvo (2016)
10.1016/j.mito.2010.03.002
Maternal diabetes and oocyte quality.
Q. Wang (2010)
10.1038/mt.2015.126
MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.
Masami Hashimoto (2015)
10.1016/j.bbagen.2011.10.014
Prevention of mitochondrial disease inheritance by assisted reproductive technologies: prospects and challenges.
A. Yabuuchi (2012)
10.1038/ncomms1503
Reprogramming within hours following nuclear transfer into mouse but not human zygotes.
D. Egli (2011)
10.1371/journal.pgen.1005241
Altered Levels of Mitochondrial DNA Are Associated with Female Age, Aneuploidy, and Provide an Independent Measure of Embryonic Implantation Potential
E. Fragouli (2015)
10.1242/jcs.02644
Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins
T. Hussein (2005)
10.1093/HUMREP/13.10.2857
Mitochondrial transfer between oocytes: potential applications of mitochondrial donation and the issue of heteroplasmy.
J. van Blerkom (1998)
Assisted reproductive technology in reproductive medicine – possibilities and limitations. Ginekol Pol 2016;87:820–823
M. Szamatowicz (2016)
Emerging therapies for mitochondrial disorders. Brain 2016;139:1633–1648
H Nightingale (2016)
10.1038/nrdp.2016.80
Mitochondrial diseases
G. Gorman (2016)
10.1093/HUMREP/DEI029
Treatment option for sperm- or oocyte-related fertilization failure: assisted oocyte activation following diagnostic heterologous ICSI.
B. Heindryckx (2005)
10.1016/j.exger.2014.03.027
In D-loop: 40years of mitochondrial 7S DNA
T. Nicholls (2014)
[Influence of maternal age on meiotic spindle and chromosome configuration of oocytes].
W. Chen (2007)
10.1093/molehr/gat013
The activity and copy number of mitochondrial DNA in ovine oocytes throughout oogenesis in vivo and during oocyte maturation in vitro
Matthew Cotterill (2013)
10.1038/sj.gt.2008.11
Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes.
M. Alexeyev (2008)
10.1093/HUMREP/16.3.513
Mitochondria in human offspring derived from ooplasmic transplantation.
J. Barritt (2001)
10.1007/s10545-012-9510-1
Erratum to: Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A>G mutation
P. Laat (2012)
10.1007/s13238-015-0177-x
Eliminate mitochondrial diseases by gene editing in germ-line cells and embryos
Si Li Wang (2015)
10.1016/0022-510X(80)90031-3
Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): Disease entity or a syndrome?: Light- and electron-microscopic studies of two cases and review of literature
N. Fukuhara (1980)
Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women.
D. Battaglia (1996)
10.1016/j.celrep.2014.05.004
Limitations of preimplantation genetic diagnosis for mitochondrial DNA diseases.
Shoukhrat Mitalipov (2014)
10.1016/j.cell.2011.08.028
Complete Kinetochore Tracking Reveals Error-Prone Homologous Chromosome Biorientation in Mammalian Oocytes
Tomoya S. Kitajima (2011)
10.1126/SCIENCE.3201231
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.
D. Wallace (1988)
10.1086/302488
Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.
S. White (1999)
10.1186/1477-7827-12-111
The impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility
H. Schatten (2014)
10.1016/S0015-0282(98)00504-4
Pregnancy following transfer of ooplasm from cryopreserved-thawed donor oocytes into recipient oocytes.
S. Lanzendorf (1999)
10.1093/HUMUPD/DML011
Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer.
E. C. Spikings (2006)
10.1007/s10815-014-0400-3
Revisiting Germinal Vesicle Transfer as a Treatment for Aneuploidy in Infertile Women with Diminished Ovarian Reserve
J. Zhang (2014)
10.1002/ANA.410160409
Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome
S. Pavlakis (1984)
10.1093/HUMREP/DEG372
Metaphase II nuclei generated by germinal vesicle transfer in mouse oocytes support embryonic development to term.
H. Liu (2003)
10.1073/PNAS.88.11.4806
Centrioles in the beginning of human development.
A. Sathananthan (1991)
10.1038/344768A0
Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification
A. Handyside (1990)
10.1016/S1472-6483(10)60497-X
Spindles, mitochondria and redox potential in ageing oocytes.
U. Eichenlaub-Ritter (2004)
10.1089/CLO.2006.0020
Effects of granulosa cell mitochondria transfer on the early development of bovine embryos in vitro.
S. Hua (2007)
10.1093/humupd/dmv024
Evolutionary defined role of the mitochondrial DNA in fertility, disease and ageing.
Auke B C Otten (2015)
10.1093/humupd/dms008
PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring.
D. Hellebrekers (2012)
10.1093/MOLEHR/4.3.269
Ooplasmic transfer in mature human oocytes.
J. Cohen (1998)
10.1093/nar/gkw676
Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs
P. A. Gammage (2016)
10.1016/S0015-0282(99)00309-X
Birth after the injection of sperm and the cytoplasm of tripronucleate zygotes into metaphase II oocytes in patients with repeated implantation failure after assisted fertilization procedures.
C. C. Huang (1999)
10.1017/S0967199400002793
The effect of temperature fluctuations on the cytoskeletal organisation and chromosomal constitution of the human oocyte.
P. Almeida (1995)
10.1101/gr.7160508
Mouse consomic strains: exploiting genetic divergence between Mus m. musculus and Mus m. domesticus subspecies.
S. Gregorová (2008)
10.1038/nprot.2010.75
Chromosome transfer in mature oocytes
M. Tachibana (2010)
10.1016/j.mito.2010.07.003
Xenomitochondrial mice: investigation into mitochondrial compensatory mechanisms.
M. Cannon (2011)
10.1093/MOLEHR/GAG077
Prospect of preimplantation genetic diagnosis for heritable mitochondrial DNA diseases.
N. Dean (2003)
COMMITTEE ON THE ETHICAL AND SOCIAL POLICY CONSIDERATIONS OF NOVEL TECHNIQUES FOR PREVENTION OF MATERNAL TRANSMISSION OF MITOCHONDRIAL DNA DISEASES
A. Claiborne (2016)
10.1016/j.fertnstert.2016.01.013
Aging and the environment affect gamete and embryo potential: can we intervene?
D. Meldrum (2016)
10.1016/j.molmed.2014.12.001
Mitochondrial replacement therapy in reproductive medicine.
D. Wolf (2015)
10.5603/GP.2016.0095
Assisted reproductive technology in reproductive medicine - possibilities and limitations.
M. Szamatowicz (2016)
10.1016/j.rbmo.2016.07.008
Pregnancy derived from human zygote pronuclear transfer in a patient who had arrested embryos after IVF.
J. Zhang (2016)
10.1056/NEJMc1500960
Mitochondrial donation--how many women could benefit?
G. Gorman (2015)
NARP and MILS syndromes
PA Almeida (2008)
10.1016/S0022-3476(05)83431-6
Maternally inherited Leigh syndrome.
E. Ciafaloni (1993)
10.1016/j.fertnstert.2013.11.030
Three-parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases.
P. Amato (2014)
10.1016/j.cmet.2016.04.004
Modifying the Mitochondrial Genome.
A. Patananan (2016)
10.1371/journal.pgen.1004315
The Challenges of Mitochondrial Replacement
P. Chinnery (2014)
10.1126/SCIENCE.6857250
Nuclear transplantation in the mouse embryo by microsurgery and cell fusion.
James H. McGrath (1983)
10.1093/HUMREP/15.9.1997
In-vitro development of mouse zygotes following reconstruction by sequential transfer of germinal vesicles and haploid pronuclei.
H. Liu (2000)
10.1016/J.FERTNSTERT.2016.08.004
First live birth using human oocytes reconstituted by spindle nuclear transfer for mitochondrial DNA mutation causing Leigh syndrome
J. Zhang (2016)
10.1038/nature11800
Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants
D. Paull (2013)
10.1093/brain/aww081
Emerging therapies for mitochondrial disorders
H. Nightingale (2016)
Cytoplasmic transfer in assisted repro
J 16513–516.Barritt (2001)
10.1126/science.aaf4777
Mitochondrial endonuclease G mediates breakdown of paternal mitochondria upon fertilization
Q. Zhou (2016)
10.1016/S1474-4422(10)70116-2
A neurological perspective on mitochondrial disease
R. McFarland (2010)
10.1093/HUMREP/16.4.730
Preliminary findings in germinal vesicle transplantation of immature human oocytes.
T. Takeuchi (2001)
10.1111/cge.12896
Genetics of mitochondrial dysfunction and infertility
L. Demain (2017)
10.1038/nature08958
Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease
L. Craven (2010)
10.1093/humupd/dmw005
Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
R. Vassena (2016)
10.1016/S0140-6736(06)68972-1
Transmission of mitochondrial DNA disorders: possibilities for the future
D. Brown (2006)
10.1093/MOLEHR/4.7.657
Multiple deletions of mitochondrial DNA are associated with the decline of motility and fertility of human spermatozoa.
S. Kao (1998)
10.1095/biolreprod.104.032391
Effect of Treating Induced Mitochondrial Damage on Embryonic Development and Epigenesis
T. Takeuchi (2005)
Mitochondrial genotype segregation during preimplantation development in mouse heteroplasmic embryos.
F. Meirelles (1998)
10.1093/humrep/des439
Preventing the transmission of pathogenic mitochondrial DNA mutations: can we achieve long-term benefits from germ-line gene transfer?
D. Samuels (2013)
10.1177/1933719115612137
Oogonial Precursor Cell-Derived Autologous Mitochondria Injection to Improve Outcomes in Women With Multiple IVF Failures Due to Low Oocyte Quality
K. Oktay (2015)
10.1016/j.celrep.2014.05.020
MtDNA segregation in heteroplasmic tissues is common in vivo and modulated by haplotype differences and developmental stage.
J. Burgstaller (2014)
10.1038/nm.2669
Oocyte formation by mitotically-active germ cells purified from ovaries of reproductive age women
Yvonne A. R. White (2012)
10.1093/humrep/dew356
PGD for the m.14487 T>C mitochondrial DNA mutation resulted in the birth of a healthy boy
Suzanne C E H Sallevelt (2017)
10.1016/j.rbmo.2010.10.011
Ooplast-mediated developmental rescue of bovine oocytes exposed to ethidium bromide.
M. R. Chiaratti (2011)
10.1038/nature14546
Metabolic rescue in pluripotent cells from patients with mtDNA disease
H. Ma (2015)
10.1016/s0015-0282(98)00549-4
In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle transfer.
J. Zhang (1999)
10.1001/ARCHOPHT.1958.00940080296016
Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases.
T. Kearns (1958)
10.1126/science.1167000
Sensing Chromosome Bi-Orientation by Spatial Separation of Aurora B Kinase from Kinetochore Substrates
Dan Liu (2009)
10.1016/j.rbmo.2015.03.012
Cytoplasm replacement following germinal vesicle transfer restores meiotic maturation and spindle assembly in meiotically arrested oocytes.
J. Zhang (2015)
10.1016/j.cell.2014.04.042
Polar Body Genome Transfer for Preventing the Transmission of Inherited Mitochondrial Diseases
T. Wang (2014)
10.1016/j.fertnstert.2012.07.1119
Blastocyst preimplantation genetic diagnosis (PGD) of a mitochondrial DNA disorder.
N. Treff (2012)
Mitochondria in human offspring
Steril (2014)
10.1093/HUMREP/16.7.1469
Pregnancy after cytoplasmic transfer in a couple suffering from idiopathic infertility: case report.
B. Dale (2001)
10.4172/2375-4508.1000154
The AUGMENT SM Treatment: Physician Reported Outcomes of the Initial Global Patient Experience
M. Fakih (2015)
10.1093/hmg/ddr373
Mitochondrial DNA disease: new options for prevention.
L. Craven (2011)
10.1093/OXFORDJOURNALS.HUMREP.A019080
Fertilization and early embryology: Influence of maternal age on meiotic spindle assembly oocytes from naturally cycling women
D. Battaglia (1996)
10.2174/0929867033456503
Medicinal and genetic approaches to the treatment of mitochondrial disease.
E. Schon (2003)
10.1038/nature02316
Germline stem cells and follicular renewal in the postnatal mammalian ovary
J. Johnson (2004)
10.1155/2015/305716
Efficient Mitochondrial Genome Editing by CRISPR/Cas9
A. Jo (2015)
10.1038/nature08368
Mitochondrial Gene Replacement in Primate Offspring and Embryonic Stem Cells
M. Tachibana (2009)
10.1097/01.ogx.0000524508.40309.08
Live Birth Derived From Oocyte Spindle Transfer to Prevent Mitochondrial Disease
J. Zhang (2017)
10.1002/ana.24362
Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
G. Gorman (2015)
10.1095/biolreprod.111.094367
Meiotic Origins of Maternal Age-Related Aneuploidy1
T. Chiang (2012)
10.1093/MOLEHR/4.1.41
Nuclear and cytoplasmic determinants involved in the regulation of mammalian oocyte maturation.
J. Fulka (1998)
10.1093/HUMUPD/DMW028
Ovarian ageing: the role of mitochondria in oocytes and follicles.
P. May-Panloup (2016)
10.1038/nature08136
A Mechanism Linking Extra Centrosomes to Chromosomal Instability
Neil J Ganem (2009)
10.1016/j.biocel.2014.08.011
Mitochondria: participation to infertility as source of energy and cause of senescence.
M. Benkhalifa (2014)
10.1093/MOLEHR/GAW062
mtDNA diversity in human populations highlights the merit of haplotype matching in gene therapies.
E. Royrvik (2016)
10.1002/stem.2221
Research into Policy: A Brief History of Mitochondrial Donation
L. Craven (2016)
10.1089/CLO.2006.0082
The kinetics of donor cell mtDNA in embryonic and somatic donor cell-derived bovine embryos.
C. Ferreira (2007)
10.1136/jmedgenet-2012-101172
Preimplantation genetic diagnosis in mitochondrial DNA disorders: challenge and success
Suzanne C E H Sallevelt (2013)
10.1155/2016/7193075
The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis
D. Cimadomo (2016)
10.1038/ng.258
The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes
T. Wai (2008)
10.1095/BIOLREPROD59.1.100
The first polar body can be used for the production of normal offspring in mice.
T. Wakayama (1998)
10.1016/j.rbmo.2016.10.003
A limited survey-based uncontrolled follow-up study of children born after ooplasmic transplantation in a single centre.
S. Chen (2016)
Skewed segregation
RB Blok (2014)
10.1093/HUMREP/DEW219
Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle.
A. De Vos (2016)
10.1016/S0140-6736(05)62353-7
Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs
J. Cohen (1997)
10.1002/emmm.201303672
Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations
P. A. Gammage (2014)
10.1371/journal.pgen.1005040
Extreme-Depth Re-sequencing of Mitochondrial DNA Finds No Evidence of Paternal Transmission in Humans
A. Pyle (2015)
10.1016/j.jare.2013.05.002
Prediction models in in vitro fertilization; where are we? A mini review
L. van Loendersloot (2014)
10.1093/humrep/den290
PGD to reduce reproductive risk: the case of mitochondrial DNA disorders.
A. Bredenoord (2008)
10.1093/humrep/deu016
A systematic analysis of the suitability of preimplantation genetic diagnosis for mitochondrial diseases in a heteroplasmic mitochondrial mouse model.
J. Neupane (2014)
10.1086/515453
Skewed segregation of the mtDNA nt 8993 (T-->G) mutation in human oocytes.
R. Blok (1997)
CRISPR/Cas9 and mitochondrial gene replacement therapy: promising techniques and ethical considerations.
S. Fogleman (2016)
10.1016/0092-8674(90)90059-N
Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation
J. Shoffner (1990)
10.1016/J.CELREP.2012.03.011
Rapid mitochondrial DNA segregation in primate preimplantation embryos precedes somatic and germline bottleneck.
H. Lee (2012)
10.1017/S0967199400001003
Quantification of mtDNA in single oocytes, polar bodies and subcellular components by real-time rapid cycle fluorescence monitored PCR.
N. Steuerwald (2000)
10.1016/j.stem.2016.04.001
Genetic Drift Can Compromise Mitochondrial Replacement by Nuclear Transfer in Human Oocytes.
M. Yamada (2016)
10.1038/ng.2007.63
A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes
L. M. Cree (2008)
10.1242/DEV.100685
Biased inheritance of mitochondria during asymmetric cell division in the mouse oocyte
C. Dalton (2013)
10.1111/cge.12557
mtDNA mutations variously impact mtDNA maintenance throughout the human embryofetal development
J. Steffann (2015)
10.1073/pnas.1206600109
Experimental evidence showing that no mitotically active female germline progenitors exist in postnatal mouse ovaries
H. Zhang (2012)
10.1095/biolreprod.108.073593
Effects of Ooplasm Manipulation on DNA Methylation and Growth of Progeny in Mice1
Yong Cheng (2009)
10.1016/j.celrep.2014.05.005
Data from artificial models of mitochondrial DNA disorders are not always applicable to humans.
J. Steffann (2014)
10.1038/nature11647
Towards germline gene therapy of inherited mitochondrial diseases
M. Tachibana (2013)
10.17226/21871
Mitochondrial Replacement Techniques
A. Claiborne (2016)
10.1073/pnas.1605844113
Autophagy and ubiquitin–proteasome system contribute to sperm mitophagy after mammalian fertilization
Won-Hee Song (2016)
10.1093/molehr/gau090
Mitochondrial DNA disease and developmental implications for reproductive strategies
J. Burgstaller (2015)
10.1111/nyas.12866
Preventing the transmission of mitochondrial DNA disorders using prenatal or preimplantation genetic diagnosis
Hubert J.M. Smeets (2015)
10.1111/acel.12368
Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging
A. Ben-Meir (2015)
10.1016/j.fertnstert.2009.03.061
Artificial oocyte activation and intracytoplasmic sperm injection.
M. Nasr-Esfahani (2010)
10.1093/MOLEHR/GAL112
mtDNA point mutations are present at various levels of heteroplasmy in human oocytes.
Lorraine Jacobs (2007)
10.1016/j.celrep.2015.10.019
Cellular Heterogeneity in the Level of mtDNA Heteroplasmy in Mouse Embryonic Stem Cells.
J. Neupane (2015)
10.1016/j.mito.2014.08.005
Mutation-free baby born from a mitochondrial encephalopathy, lactic acidosis and stroke-like syndrome carrier after blastocyst trophectoderm preimplantation genetic diagnosis.
B. Heindryckx (2014)
Modifying the mitochondrial genome to enhance animal production
J. C. S. John (2014)
10.1016/j.stem.2016.10.001
Functional Human Oocytes Generated by Transfer of Polar Body Genomes.
H. Ma (2017)
10.1093/humrep/dev336
Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178,898 women.
D. McLernon (2016)
10.1093/molehr/gap049
The role of centrosomes in mammalian fertilization and its significance for ICSI.
H. Schatten (2009)
10.1126/science.1237146
Mitochondrial Replacement, Evolution, and the Clinic
K. Reinhardt (2013)
10.1002/emmm.200900055
A non-enzymatic function of 17β-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival
Katharina Rauschenberger (2010)
10.1016/j.fertnstert.2013.05.053
Polar body biopsy.
M. Montag (2013)
Adult phenotype in the mouse can be affected by epigenetic events in the early embryo.
W. Reik (1993)
10.1038/srep03844
Therapeutic potential of somatic cell nuclear transfer for degenerative disease caused by mitochondrial DNA mutations
Gareth D. Greggains (2014)
10.1002/humu.21417
Segregation of mtDNA Throughout Human Embryofetal Development: m.3243A > G as a Model System
S. Monnot (2011)
10.1038/35000654
Mitochondria and the death of oocytes
D. Krakauer (2000)
10.1038/nature20592
Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations
Eunju Kang (2016)
10.1038/nature18303
Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease
L. Hyslop (2016)
10.5653/cerm.2014.41.2.41
In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities
E. Chang (2014)
10.1016/j.ajhg.2011.03.010
Poor correlations in the levels of pathogenic mitochondrial DNA mutations in polar bodies versus oocytes and blastomeres in humans.
N. Gigarel (2011)
Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embryonic karyoplast transplantation.
F. Meirelles (1997)
10.1002/stem.1887
Concise Reviews: Assisted Reproductive Technologies to Prevent Transmission of Mitochondrial DNA Disease
J. Richardson (2015)
10.1038/ejhg.2014.35
A national perspective on prenatal testing for mitochondrial disease
V. Nesbitt (2014)
10.1136/jmg.2005.032326
Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis
J. Steffann (2005)
10.1002/AJMG.1380
Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options.
D. Thorburn (2001)
10.1016/J.FERTNSTERT.2004.07.136
Mitochondria transfer (mit) into oocyte from autologous cumulus granulosa cells (cgcs)
C. R. Tzeng (2004)
10.1016/j.mito.2012.04.002
Poor correlation between polar bodies and blastomere mutation load in a patient with m.3243A>G tRNALeu(UUR) point mutation.
M. Vandewoestyne (2012)
10.1126/science.1240617
Single-Cell DNA-Methylation Analysis Reveals Epigenetic Chimerism in Preimplantation Embryos
C. Lorthongpanich (2013)
10.1002/1097-010X(20010415/30)289:5<322::AID-JEZ6>3.0.CO;2-B
Mouse-rabbit germinal vesicle transfer reveals that factors regulating oocyte meiotic progression are not species-specific in mammals.
G. Li (2001)
10.1016/j.mito.2014.09.003
Assessment of nuclear transfer techniques to prevent the transmission of heritable mitochondrial disorders without compromising embryonic development competence in mice.
Jitesh Neupane (2014)
Deficit of mitochondria-derived ATP during oxidative stress impairs mouse MII oocyte spindles
Who Collaborative (2006)
10.1038/331717A0
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
I. Holt (1988)
10.1016/j.cell.2015.03.051
Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing
P. Reddy (2015)
10.1242/dmm.019323
A Drosophila model for mito-nuclear diseases generated by an incompatible interaction between tRNA and tRNA synthetase
Marissa A. Holmbeck (2015)
10.1093/HUMREP/14.5.1312
A reliable technique of nuclear transplantation for immature mammalian oocytes.
T. Takeuchi (1999)
10.1093/humupd/dmq002
Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells.
J. S. St John (2010)
10.1093/HMG/10.22.2469
Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to differences in respiratory chain function or efficiency of replication.
B. Battersby (2001)
10.1093/HUMREP/DEH826
Transfer of germinal vesicle to ooplasm of young mice could not rescue ageing-associated chromosome misalignment in meiosis of oocytes from aged mice.
Longbo Cui (2005)
10.1073/PNAS.89.16.7370
A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues.
G. Cortopassi (1992)
10.1530/JRF.0.1100263
Participation of the female pronucleus derived from the second polar body in full embryonic development of mice.
T. Wakayama (1997)



This paper is referenced by
10.1186/s13578-019-0360-5
Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
H. Mobarak (2019)
10.1080/20502877.2018.1440725
Scientific and Ethical Issues in Mitochondrial Donation
L. Craven (2018)
10.1101/603282
Deleterious in late life mitochondrial alleles and aging: secrets of Japanese centenarians
A. Mikhailova (2019)
Research Progress on Mitochondrial Replacement Therapies in Reproductive Medicine
Lingbin Qi (2019)
10.3390/ijms21165880
Mitochondrial Genetic Drift after Nuclear Transfer in Oocytes
M. Yamada (2020)
10.1007/978-3-319-74645-6_1
Mitochondrial Donation and UK Biomedical Politics
R. Dimond (2018)
10.1042/EBC20170113
Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome
P. K. Rai (2018)
10.17116/REPRO20192506144
Использование различных методов биопсии эмбриона для преимплантационного генетического тестирования (обзор литературы)
Kseniya Vladislavovna Krasnopolskaya (2019)
10.1111/1471-0528.15667
A case‐comparison study of pregnant women with mitochondrial disease – what to expect?
C. Feeney (2019)
10.1097/GRF.0000000000000327
Futuristic Look at Genetic and Birth Defect Diagnoses and Treatments.
Anthony R. Gregg (2017)
10.23736/S0031-0808.18.03510-3
Mitochondria and reproduction: possibilities for testing and treatment.
Stine Gry Kristensen (2019)
10.1007/s40142-018-0138-9
Mitochondrial Disease: Advances in Clinical Diagnosis, Management, Therapeutic Development, and Preventative Strategies
C. Muraresku (2018)
10.1042/CS20180436
Recent developments in genetic/genomic medicine
R. Horton (2019)
10.3390/genes11020192
Pathogenic Mitochondria DNA Mutations: Current Detection Tools and Interventions
M. F. Mustafa (2020)
10.1007/s11883-020-00873-5
Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations
A. Orekhov (2020)
10.1093/molehr/gaz062
Comparative analysis of different nuclear transfer techniques to prevent the transmission of mitochondrial DNA variants.
M. Tang (2019)
10.5935/1518-0557.20190086
Three-parent babies: Mitochondrial replacement therapies
Hana Carolina Moreira Farnezi (2020)
10.1002/rmb2.12335
Improvement of early developmental competence of postovulatory‐aged oocytes using metaphase II spindle injection in mice
T. Ogawa (2020)
Semantic Scholar Logo Some data provided by SemanticScholar